Joseph Cooper - Jan 1, 2023 Form 3/A - Amendment Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Director
Signature
/s/ Joseph Cooper
Stock symbol
QNRX
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
3/A - Amendment
Date filed
3/7/2023, 06:13 PM
Date Of Original Report
Jan 3, 2023
Next filing
Oct 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QNRX Share Option (right to buy) Jan 1, 2023 Ordinary Shares 64.3M $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's original Form 3 incorrectly indicated the options vest in four equal annual installments beginning on April 12, 2023; however, the options vest in three equal annual installments beginning on April 12, 2023.